復旦復華(600624.SH):奉賢區國資委批准奉投集團無償受讓公司18.74%股權及復旦復華藥業10%股權
格隆匯5月15日丨復旦復華(600624.SH)公佈,2020年5月14日,公司收到上海奉賢投資(集團)有限公司(“奉投集團”)發來的《關於無償受讓復旦大學持有的上海復旦復華科技股份有限公司18.74%股權及持有的上海復旦復華藥業有限公司10%股權的告知函》(“告知函”):為配合中央深改委關於高校所屬企業體制改革工作要求,同時進一步深化奉賢區國資國企改革,推動奉賢區域經濟更高質量發展,上海奉賢投資(集團)有限公司同意無償受讓復旦大學持有的上海復旦復華科技股份有限公司18.74%股權及持有的上海復旦復華藥業有限公司10%股權。上述無償劃轉事項已經奉賢區委、區政府會議討論通過,並獲得奉賢區國資委批覆同意。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.